Login / Signup

Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia.

Hyun Don YunDawn K SchirmMartin FelicesJeffrey S MillerCraig E Eckfeldt
Published in: Blood advances (2020)
Keyphrases
  • liver failure
  • single cell
  • acute myeloid leukemia
  • respiratory failure
  • cell therapy
  • bone marrow
  • drug induced
  • stem cells
  • mesenchymal stem cells